Sarah Maloney
615 St Kilda Road
Melbourne, VIC 3004, Australia
Melbourne, VIC 3004, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Total lesion glycolysis is a promising predictor of chemo-response in pancreatic cancer patients treated with neoadjuvant chemotherapy prior to surgery.
Journal: European journal of clinical investigation
Published: January 14, 2025
Promising biomarker panel to monitor therapeutic efficacy of neoadjuvant chemotherapy in pancreatic cancer patients.
Journal: European journal of clinical investigation
Published: August 13, 2024
MuscleMap: An Open-Source, Community-Supported Consortium for Whole-Body Quantitative MRI of Muscle.
MuscleMap: An Open-Source, Community-Supported Consortium for Whole-Body Quantitative MRI of Muscle.
Journal: Journal of imaging
Published: June 27, 2024
Serum and tissue metallome of pancreatic ductal adenocarcinoma.
Journal: Cancer science
Published: December 08, 2023
The role of diagnostic, prognostic, and predictive biomarkers in the management of early pancreatic cancer.
Journal: Journal of cancer research and clinical oncology
Published: June 10, 2023
The Prognostic and Predictive Role of the Neutrophil-to-Lymphocyte Ratio (NLR), Platelet-to-Lymphocyte Ratio (PLR), and Lymphocyte-to-Monocyte Ratio (LMR) as Biomarkers in Resected Pancreatic Cancer.
Journal: Journal of clinical medicine
Published: January 13, 2023
FOLFIRINOX or Gemcitabine-based Chemotherapy for Borderline Resectable and Locally Advanced Pancreatic Cancer: A Multi-institutional, Patient-Level, Meta-analysis and Systematic Review.
Journal: Annals of surgical oncology
Published: November 01, 2022
Optimal Upfront Treatment in Surgically Resectable Pancreatic Cancer Candidates: A High-Volume Center Retrospective Analysis.
Journal: Journal of clinical medicine
Published: April 18, 2021
Survival in borderline resectable and locally advanced pancreatic cancer is determined by the duration and response of neoadjuvant therapy.
Journal: European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology
Published: January 23, 2021
A unique urinary metabolomic signature for the detection of pancreatic ductal adenocarcinoma.
Journal: International journal of cancer
Published: June 24, 2020
PSMD11, PTPRM and PTPRB as novel biomarkers of pancreatic cancer progression.
Journal: Biochimica et biophysica acta. General subjects
Published: April 28, 2020
Last Updated: 09/26/2026